Cancer clinical trials in the region Grand Est
196 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Lymphoma
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M4
B cell lymphoma
Large B cell lymphoma
None
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Endometrial cancer
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M3
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Locally Advanced
Metastatic
ARID1A
1
2
3 or more
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Lymphoma
#NCT04104776
#2023-508002-20-00
Etude du CPI-0209 chez des patients atteints de tumeurs solides et de lymphomes avancés - Cohorte M4
T cell lymphoma
Peripheral T cell lymphoma
None
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Constellation Pharmaceutique
Phase 1 / Phase 2
Breast cancer
Lung cancer
#NCT05706129
#2023-504254-35-00
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
HER2 Negative
HR Negative
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
#2023-504254-35-00
Clear cell carcinoma
Locally Advanced
Metastatic
2
3 or more
Targeted therapy
Immunotherapy
Targeted therapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Kidney cancer
#NCT05706129
#2023-504254-35-00
Other
Localized
None
Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT05706129
#2023-504254-35-00
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
Targeted therapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Pancreas cancer
#NCT05706129
#2023-504254-35-00
Adenocarcinoma
Locally Advanced
Metastatic
1
2
3 or more
Chemotherapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Debiopharm International SA
Phase 1 / Phase 2
Prostate cancer
#NCT06353386
#2023-506288-33-00
Adenocarcinoma
Metastatic Castration-resistant
1
2
3 or more
Hormone therapy
Hormone therapy
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2
CLL & Richter's syndrome
#NCT04623541
Richter's syndrome
None
1
2
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Genmab